Results
1 -
10 of
83A Phase 1 study of UCN-01 in combination with irinotecan in patients with resistant solid tumor malignancies, Cancer Chemotherapy and Pharmacology Phase I and pharmacokinetic study of UCN-01 in combination with irinotecan in patients with solid tumors, Cancer Chemotherapy and Pharmacology UCN-01 Enhances the In Vitro Toxicity of Clinical Agents in Human Tumor Cell Lines, Investigational New Drugs In Vivo Resistance, Cancer Drug Resistance Identification of indolepyruvic acid as an intermediate of rebeccamycin biosynthesis, Journal of Industrial Microbiology Clinical importance of DNA repair inhibitors in cancer therapy, memo - Magazine of European Medical Oncology Natural Compounds as Specific Inhibitors of Cyclin-Dependent Kinases u2013 Past, Present and Future, Natural compounds as inducers of cell death New Indole-Containing Medicinal Compounds, Heterocyclic Scaffolds II: Inhibitors of cyclin-dependent kinase modulators for cancer therapy, Advances in Targeted Cancer Therapy